Does anyone want to share their thoughts on this action from
JNJ?
Lynda Feit on
I'll share our thoughts, and conclusion:
Here is what I thought I understood based on what the docs provided. I shared the following with our Club members:
There are 2 companies: J&J and Kenvue. J&J owns a piece of Kenvue. Kenvue's business is the 'Consumer Health' part of J&J, but the companies are separate. For those interested in the offer, they will receive approximately $107.53 of Kenvue stock for every $100 of J&J shares. When the 'deal' is finished, J&J will STILL own 9.5% of the Kenvue company. If we choose to participate, it will reduce the number of J&J shares we currently own, and we'll pick up some number of Kenvue shares.
Kenvue is listed on the stock market under the call letters KVUE. It is a subsidiary of J&J, and will continue to be.
Kenvue businesses are:
1, Self Care: cough, cold, allergy, pain care, digestive health, smoking cessation; includes Tylenol, Nicorette, Zyrtec brands.
2, Skin Health & Beauty: face & body care, hair care, sun and other care products; includes Neutrogena, Aveeno, OXG brands.
3. Essential Health: oral & baby care, women's health, wound care; includes Listerine, Band-Aid, Stayfree brands..
Perhaps others in the Club could do some additional research on this to help us understand why it would or would not be beneficial for us to want to participate. Personally, since J&J will continue to own a piece of Kenvue, I don't understand why we would want shares of a company whose annual dividends are less than J&J's, and a company which will continue to be a subsidiary of J&J anyway.
So unless someone can help me see it differently, my vote is no, don't bother.
Other Club members also did research. Then we took a vote. The majority of our members voted to not participate in the offering.
Does anyone want to share their thoughts on this action from
JNJ?
Sharon Holley on
Jnj currently owns almost 90 percent of kvue, so the income flows to the parent, which is jnj. After the spin off, they will only own 9.5 percent and will only receive the dividends from the kvue, not all the income. A good question is, how much of the income or profit will be transferred to kvue and not available to jnj shareholders?
This happened when att spun off part of its business. Their dividend was cut in half.
How much of jnj's dividend will be in kvue?
If you don't own kvue's shares your dividends could and probably will be reduced.
On Wednesday, August 9, 2023, 10:22 AM, Lynda Feit via bivio.com <user*26876200001@bivio.com> wrote:
I'll share our thoughts, and conclusion:
Here is what I thought I understood based on what the docs provided. I shared the following with our Club members:
There are 2 companies: J&J and Kenvue. J&J owns a piece of Kenvue. Kenvue's business is the 'Consumer Health' part of J&J, but the companies are separate. For those interested in the offer, they will receive approximately $107.53 of Kenvue stock for every $100 of J&J shares. When the 'deal' is finished, J&J will STILL own 9.5% of the Kenvue company. If we choose to participate, it will reduce the number of J&J shares we currently own, and we'll pick up some number of Kenvue shares.
Kenvue is listed on the stock market under the call letters KVUE. It is a subsidiary of J&J, and will continue to be.
Kenvue businesses are:
1, Self Care: cough, cold, allergy, pain care, digestive health, smoking cessation; includes Tylenol, Nicorette, Zyrtec brands.
2, Skin Health & Beauty: face & body care, hair care, sun and other care products; includes Neutrogena, Aveeno, OXG brands.
3. Essential Health: oral & baby care, women's health, wound care; includes Listerine, Band-Aid, Stayfree brands..
Perhaps others in the Club could do some additional research on this to help us understand why it would or would not be beneficial for us to want to participate. Personally, since J&J will continue to own a piece of Kenvue, I don't understand why we would want shares of a company whose annual dividends are less than J&J's, and a company which will continue to be a subsidiary of J&J anyway.
So unless someone can help me see it differently, my vote is no, don't bother.
Other Club members also did research. Then we took a vote. The majority of our members voted to not participate in the offering.
Jnj currently owns almost 90 percent of kvue, so the income flows to the parent, which is jnj. After the spin off, they will only own 9.5 percent and will only receive the dividends from the kvue, not all the income. A good question is, how much of the income or profit will be transferred to kvue and not available to jnj shareholders?
This happened when att spun off part of its business. Their dividend was cut in half.
How much of jnj's dividend will be in kvue?
If you don't own kvue's shares your dividends could and probably will be reduced.
Here is what I thought I understood based on what the docs provided. I shared the following with our Club members:
There are 2 companies: J&J and Kenvue. J&J owns a piece of Kenvue. Kenvue's business is the 'Consumer Health' part of J&J, but the companies are separate. For those interested in the offer, they will receive approximately $107.53 of Kenvue stock for every $100 of J&J shares. When the 'deal' is finished, J&J will STILL own 9.5% of the Kenvue company. If we choose to participate, it will reduce the number of J&J shares we currently own, and we'll pick up some number of Kenvue shares.
Kenvue is listed on the stock market under the call letters KVUE. It is a subsidiary of J&J, and will continue to be.
Kenvue businesses are:
1, Self Care: cough, cold, allergy, pain care, digestive health, smoking cessation; includes Tylenol, Nicorette, Zyrtec brands.
2, Skin Health & Beauty: face & body care, hair care, sun and other care products; includes Neutrogena, Aveeno, OXG brands.
3. Essential Health: oral & baby care, women's health, wound care; includes Listerine, Band-Aid, Stayfree brands..
Perhaps others in the Club could do some additional research on this to help us understand why it would or would not be beneficial for us to want to participate. Personally, since J&J will continue to own a piece of Kenvue, I don't understand why we would want shares of a company whose annual dividends are less than J&J's, and a company which will continue to be a subsidiary of J&J anyway.
So unless someone can help me see it differently, my vote is no, don't bother.
Other Club members also did research. Then we took a vote. The majority of our members voted to not participate in the offering.
Jnj currently owns almost 90 percent of kvue, so the income flows to the parent, which is jnj. After the spin off, they will only own 9.5 percent and will only receive the dividends from the kvue, not all the income. A good question is, how much of the income or profit will be transferred to kvue and not available to jnj shareholders?
This happened when att spun off part of its business. Their dividend was cut in half.
How much of jnj's dividend will be in kvue?
If you don't own kvue's shares your dividends could and probably will be reduced.
Here is what I thought I understood based on what the docs provided. I shared the following with our Club members:
There are 2 companies: J&J and Kenvue. J&J owns a piece of Kenvue. Kenvue's business is the 'Consumer Health' part of J&J, but the companies are separate. For those interested in the offer, they will receive approximately $107.53 of Kenvue stock for every $100 of J&J shares. When the 'deal' is finished, J&J will STILL own 9.5% of the Kenvue company. If we choose to participate, it will reduce the number of J&J shares we currently own, and we'll pick up some number of Kenvue shares.
Kenvue is listed on the stock market under the call letters KVUE. It is a subsidiary of J&J, and will continue to be.
Kenvue businesses are:
1, Self Care: cough, cold, allergy, pain care, digestive health, smoking cessation; includes Tylenol, Nicorette, Zyrtec brands.
2, Skin Health & Beauty: face & body care, hair care, sun and other care products; includes Neutrogena, Aveeno, OXG brands.
3. Essential Health: oral & baby care, women's health, wound care; includes Listerine, Band-Aid, Stayfree brands..
Perhaps others in the Club could do some additional research on this to help us understand why it would or would not be beneficial for us to want to participate. Personally, since J&J will continue to own a piece of Kenvue, I don't understand why we would want shares of a company whose annual dividends are less than J&J's, and a company which will continue to be a subsidiary of J&J anyway.
So unless someone can help me see it differently, my vote is no, don't bother.
Other Club members also did research. Then we took a vote. The majority of our members voted to not participate in the offering.